Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (131-140 of 545) with videos related to

Pageof 55
Sort By:
Cleveland Clinic Journal of Medicine|October 31, 1998
Why should cancer patients participate in clinical trials?M Markman
Cleveland Clinic Journal of Medicine|February 2, 1999
Diagnosis and management of superior vena cava syndromeM Markman
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Intraperitoneal chemotherapy for ovarian carcinomaM Markman
Journal of Cancer Research and Clinical Oncology|August 27, 1998
A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancerM Markman
Journal of Cancer Research and Clinical Oncology|August 27, 1998
Thirty-ninth annual meeting of the American Society of Hematology. 5-9 December 1997, San DiegoM Markman
Journal of Biological Response Modifiers|August 1, 1987
Intracavitary administration of biological agentsM Markman
Current Oncology Reports|August 8, 2001
Is it good clinical judgment or selection bias?M Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Supportive careM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Supportive careM Markman
Oncology (Williston Park, N.Y.)|March 1, 1987
Current status of intracavitary chemotherapyM Markman
Pageof 55

Showing results (131-140 of 545) with videos related to

Sort By:
Pageof 55
Cleveland Clinic Journal of Medicine|October 31, 1998
Why should cancer patients participate in clinical trials?M Markman
Cleveland Clinic Journal of Medicine|February 2, 1999
Diagnosis and management of superior vena cava syndromeM Markman
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Intraperitoneal chemotherapy for ovarian carcinomaM Markman
Journal of Cancer Research and Clinical Oncology|August 27, 1998
A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancerM Markman
Journal of Cancer Research and Clinical Oncology|August 27, 1998
Thirty-ninth annual meeting of the American Society of Hematology. 5-9 December 1997, San DiegoM Markman
Journal of Biological Response Modifiers|August 1, 1987
Intracavitary administration of biological agentsM Markman
Current Oncology Reports|August 8, 2001
Is it good clinical judgment or selection bias?M Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Supportive careM Markman
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Supportive careM Markman
Oncology (Williston Park, N.Y.)|March 1, 1987
Current status of intracavitary chemotherapyM Markman
Pageof 55